Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation.

1st Department of Neonatology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Diabetes & Metabolism (Impact Factor: 2.39). 02/2010; 36(1):58-63. DOI: 10.1016/j.diabet.2009.06.010
Source: PubMed

ABSTRACT The objectives of the present study were to determine whether or not increased serum ferritin in women with premature labour is associated with gestational diabetes mellitus (GDM) and intra-uterine growth retardation (IUGR) and, if so, whether or not such increased levels reflect excess maternal iron stores, and have an effect on neonatal iron status and outcome.
This prospective, single-hospital, observational study involved 63 mothers and their 90 preterm neonates. Full blood counts as well as serum ferritin, soluble transferrin receptor (sTfR) and erythropoietin concentrations were compared across the three study groups based on maternal ferritin levels at the time of delivery. Perinatal history, neonatal morbidity and early outcomes were also assessed.
High maternal ferritin levels were significantly associated with higher rates of GDM and IUGR. However, there was no correlation between maternal ferritin and sTfR levels or between maternal and neonatal iron status.
Elevated maternal ferritin is not a reflection of excess iron stores, but is related to an increased risk of GDM or IUGR. Also, maternal ferritin levels are not associated with either neonatal iron status or neonatal outcomes.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Observational studies suggest that high iron intake during pregnancy is associated with the risk of gestational diabetes. As such studies are prone to bias, we re-analysed data from a randomised controlled trial of iron supplementation to see whether it supports the risk found in observational studies. The trial was conducted in primary health care setting in five municipalities in Finland in 1985-1986. The participants were 2944 women (95% of pregnant women in the area) who were randomly allocated either to (1) the selective iron group (elemental iron 50 mg twice a day only if diagnosed as anaemic, continuing until their haemoglobin increased to 110 g L(-1) ) or (2) the routine iron group (elemental iron 100 mg day(-1) throughout the pregnancy regardless of haemoglobin level). The numbers of women in the analyses were 1358 and 1336, respectively. The main outcome measure was a composite variable including any glucose intolerance-related outcome (e.g. glucosuria, gestational diabetes, large-for-gestational-age child) in mothers' or children's patient records during pregnancy and post-partum. There were no statistically significant differences in the incidence of the primary outcome between the selective iron and the routine iron groups (13.0 vs. 11.0%, P = 0.12). The most common outcome was large-for-gestational-age calculated from children's hospital data (8.3 vs. 8.2%, P = 0.95). The results were mainly similar when stratified by the mothers' baseline haemoglobin level, body mass index or gestational weight gain. Routine iron supplementation throughout pregnancy did not increase the risk of glucose intolerance during pregnancy. The results need to be confirmed in future trials.
    Maternal and Child Nutrition 07/2014; · 2.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Both iron deficiency and hyperglycemia are highly prevalent globally for pregnant women. Iron supplementation is recommended during pregnancy to control iron deficiency. The purposes of the review are to assess the oxidative effects of iron supplementation and the potential relationship between iron nutrition and gestational diabetes. High doses of iron (~relative to 60 mg or more daily for adult humans) can induce lipid peroxidation in vitro and in animal studies. Pharmaceutical doses of iron supplements (e.g., 10× RDA or more for oral supplements or direct iron supplementation via injection or addition to the cell culture medium) for a short or long duration will induce DNA damage. Higher heme-iron intake or iron status measured by various biomarkers, especially serum ferritin, might contribute to greater risk of gestational diabetes, which may be mediated by iron oxidative stress though lipid oxidation and/or DNA damage. However, information is lacking about the effect of low dose iron supplementation (≤60 mg daily) on lipid peroxidation, DNA damage and gestational diabetes. Randomized trials of low-dose iron supplementation (≤60 mg daily) for pregnant women are warranted to test the relationship between iron oxidative stress and insulin resistance/gestational diabetes, especially for iron-replete women.
    Nutrients 01/2014; 6(9):3968-3980. · 3.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Background: Gestational diabetes mellitus (GDM) has been observed to be associated with increased perinatal morbidity and mortality. GDM affects approximately 7% of all pregnancies. The objective of the present study was to establish correlation of serum iron, phosphorous and hemoglobin levels in women with carbohydrate tolerance in gestational diabetes mellitus and to find out its association with gestational diabetes mellitus (GDM). Methods: The study involved screening of 100 pregnant women with gestational period of 24 – 28 weeks, for carbohydrate tolerance and prevalence of gestational diabetes mellitus. We estimated fasting glucose, post load glucose, serum iron, serum phosphorous, and hemoglobin in all 100 pregnant women selected for this study. The study was carried out in the department of OBG in collaboration with department of biochemistry. Open Access Results: In the present study, prevalence of Gestational Diabetes Mellitus is 8%. Both fasting and post serum glucose levels are significantly high in cases of Gestational Diabetes Mellitus. We observed increase in serum iron level for gestational diabetes mellitus mothers and is associated with carbohydrate tolerance. However, there was no correlation observed with phosphorous and hemoglobin levels in GDM mothers. Conclusion: Present study showed elevated serum iron levels correlates with the development of Gestational Diabetes Mellitus. Serum phosphorous and hemoglobin concentrations have not shown any significant variation.
    Journal of Diabetes & Metabolism 06/2013; 4(5).